диссертации / 121

91

Новиков А.А., Новикова Д.С., Насонов Е.Л. // Терапевтический архив . –2007.

– №5. – С.9-14.

18.Мясоедова Е.Е. Структурно-функциональные особенности миокарда левого желудочка и эндотелиальная дисфункция при ревматоидном артрите в зависимости от наличия артериальной гипертонии. / Мясоедова Е.Е., Мясоедова С.Е., Омельяненко М.Г., Обжерина С.В. // Научно-практическая ревматология. – 2007. – №3. – С.15-20.

19.Никитина H.М. Определение риска развития сердечно-сосудистых заболеваний у больных ревматоидным артритом. /Никитина H.М, Ребров А.П.

// Терапевтический архив. – 2009. – №6. – С.29-34.

20.del Rincon I.D. High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. /del Rincon I.D., Williams K., Stern M.P., Freeman G.L., Escalante A. // Arthritis Rheum. – 2001.

–Vol.44(12). – P.2737-2745.

21.Gonzalez A. Do cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in non-rheumatoid arthritis patients? / Gonzalez A., Maradit-Kremers H., Crowson C.S., Ballman K.V., Roger V.L., Jacobsen S.J., O'Fallon W.M., Gabriel S.E.// Ann Rheum Dis.

–2008. –Vol.67(1). – P.64-69.

22.Sattar N. Explaining how "high-grade" systemic inflammation accelerates vascular risk in rheumatoid arthritis. / Sattar N., McCarey D.W., Capell H., McInnes I.B. // Circulation. – 2003 Dec. – Vol.108(24). – P.2957-2963.

23.Solomon D.H. Patterns of cardiovascular risk in rheumatoid arthritis. / Solomon D.H., Goodson N.J., Katz J.N., Weinblatt M.E., Avorn J, Setoguchi S., Canning C., Schneeweiss S. // Ann Rheum Dis. – 2006. –Vol.65(12). – P.1608-1612.

92

24.Насонов Е.Л. Поражение сосудов при ревматических заболеваниях: связь с атеросклерозом. Васкулиты и васкулопатии. / Насонов Е.Л., Алекберова З.С., Карпов Ю.А., Попоква Т.В., Фомичева О.А, Баранов А.А., Шилкина Н.П. – Ярославль: Верхняя Волга, 1999. – 574-592 c.

25.Ross R. Atherosclerosis – an inflammatory disease. / Ross R. // N Engl J Med

– 1999. –Vol.340. – P.115-126.

26.Rho Y.H. Inflammatory mediators and premature coronary atherosclerosis in rheumatoid arthritis. / Rho Y.H., Chung C.P., Oeser A., Solus J., Asanuma Y., Sokka T., Pincus T., Raggi P., Gebretsadik T., shintani A., Stein C.M. // Arthritis Rheum. – 2009. –Vol. 61(11). – P.1580-1585.

27.Hannawi S. Atherosclerotic disease is increased in recent-onset rheumatoid arthritis: a critical role for inflammation. / Hannawi S., Haluska B., Marwick T.H., Thomas R. // Arthritis Res Ther. – 2007. – Vol.9(6). – P.116.

28.del Rincon I.D. Association between carotid atherosclerosis and markers of inflammation in rheumatoid arthritis patient and healthy subjects. del Rincon I.D.,

Williams K., Stern M.P., Freeman G.L. et.al. / Arthritis Rheum // – 2003.

–Vol.48(7). – P.1833-1840.

29.Насонов Е.Л. Проблема атеротромбоза в ревматологии. / Насонов Е.Л. //

Вестн РАМН. – 2003. – №7. – C.6-10.

30.Попкова Т.В. Атеросклероз при ревматических заболеваниях. Ревматология. Клинические рекомендации. / Попкова Т.В., Новиков Д.С., Насонов Е.Л.; под ред. Е.Л. Насонова. М. – М: ГЭОТАР-Медиа, 2010. – 678702 c.

31.Shoenfeld Y. Accelerated atherosclerosis in autoimmune rheumatic diseases. / Shoenfeld Y., Gerli R., Doria A., Matsuura E., Cerinic M.M., Ronda N., Jara L.J.,

93

Abu-Shakra M., Meroni P.L., Sherer Y. // Circulation. – 2005. –Vol.112(21).

–P.3337-3347.

32.Roman M.J. Preclinical carotid atherosclerosis in patients with rheumatoid arthritis. / Roman M.J., Moeller E., Davis A., Paget S.A., Crow M.K., Lockshin M.D., Sammaritano L., Devereux R.B., Schwartz J.E., Levine D.M., Salmon J.E. // Ann Intern Med. – 2006. – Vol.144(4). – P.249-256.

33.Cavagna L. Atherosclerosis and rheumatoid arthritis: more than a simple association. / Cavagna L., Caporali R., Boffini N., Cagnotto G, Inverardi F., Grosso V. // Mediators Inflamm. – 2012. – Sep 13.

34.Van Sijl A.M. Different type of carotid arterial wall remodeling in rheumatoid arthritis compared with healthy subjects: a case-control study. /Van Sijl A.M., Van Den Hurk K., Peters M.J., Van Halm V.P., Nijpels G., Stehouwer C.D., Smulders Y.V., Voskuyl A.E., Dekker J.M., Nurmohamed M.T. // J Rheumatol. – 2012. Vol.39(12). – P.2261-2266.

35.Ridker P.M. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. / Ridker P.M., Rifai N., Rose L., Buring J.E., Cook N.R. // N Engl J Med – 2002. –Vol.347(20).

–P.1557-1565.

36.Danesh J C-reactive protein in healthy and in sick populations. / Danesh J., Pepys M.B. // Eur Heart J. – 2000. –Vol.21(19). – P. 1564-1565.

37.Cao J.J. C-reactive protein, carotid intima-media thickness, and incidence of ischemic stroke in the elderly: the Cardiovascular Health Study. / Cao J.J., Thach C., Manolio T.A., Psaty B.M., Kuller L.H., Chaves P.H., Polak J.F., Sutton-Tyrrell K., Herrington D.M., Price T.R., Cushman M. // Circulation. – 2003. –Vol.108(2).

–P.166-170.

94

38. Giles J.T. Longitudinal predictors of progression of carotid atherosclerosis in rheumatoid arthritis. / Giles J.T., Post W.S., Blumenthal R.S., Polak J., Petri M., Gelber A.C., Szklo M., Bathon J.M. // Arthritis Rheum. – 2011. –Vol. 63(11).

–P.3216-3225.

39.Шостак Н.А Ревматоидная болезнь сердца: клинико-интсрументальные параллели и новые перспективы лечения. / Шостак Н.А., Махнырь Е.Ф., Голоухова Л.М. // Фарматека. – 2005. – №8. – C.50-53.

40.Красносельский М.Я. Тканевая допплерография миокарда в диагностике поражения миокарда у больных ревматоидным артритом. / Красносельский

М.Я., Братанова М.З., Полупан А.А., Цурко В.В. // Кардиология – 2007.

–№10. – Т.47. – C.59-62.

41.Махнырь Е.Ф. Клинико-интсрументальная диагностика поражения сердца

…канд.мед.наук / Махнырь Е.Ф. - М, 2004.

42.Колотова Г.Б. Структурно-функциональное состояние левых отделов сердца у больных ревматоидным артритом. /Колотова Г.Б., Завалина Д.Е., Гришина И.Ф. //Научно-практическая ревматология – 2007. – №1. – C.22-27.

43.Аничков Д.А. Ревматоидный артрит. Руководство по неишемической кардиологии/ Аничков Д.А., Шостак Н.А.; под ред. Н.А. Шостак. – Москва: ГЭОТАР-Медиа, 2009. – 48-63 с.

44.Killinger L.C. Case 5/2001 - Heart failure and insufficiency of the aortic and mitral valves in a 68-year-old woman with rheumatoid arthritis. Clinicopathologic session. / Killinger L.C., Gutierrez P.S. // Arq Bras Cardiol. – 2001. –Vol.77(4).

– P.369-376.

95

45.Rexhepaj N. Left and right ventricular diastolic functions in patients with rheumatoid arthritis without clinically evident cardiovascular disease. / Rexhepaj N., Bajraktari G., Berisha I., Beqiri A., Shatri F., Hima F., Elezi S., Ndrepepa G. // Int J Clin Pract. – 2006. –Vol.60(6). – P.683-688.

46.Levy D. Prognostic implications of echocardiographically determined left vetricular mass in the Framingham Heart Study. / Levy D., Garrison R.J., Savage

D.D., Kannel W.B., Castelli W.P. // N Engl J Med. – 1990. –Vol. 322(22).

–P.1561-1566.

47.Bikkina M. Left ventricular mass and risk of stroke in an eldery cohort./ Bikkina M., Levy D., Evans J.C., Larson M.G., Benjamin E.J., Wolf P.A., Castelli W.P. // The Framingham Heart Study. JAMA. – 1994. –Vol.272(1). – P.33-36.

48.Novo S. Increased prevalence of cardiac arrhythmias and transient episodes of myocardial ishemia in hypertensives with left ventricular hypertrophy but without clinical history of coronary heart disease. / Novo S., Barbagallo M., Abrignani M.G., Nardi E., Di Maria G.U., Longo B., Mistretta A., Strano A. // Am J Hypertens. – 1997. –Vol.10 (8). – P.843-851.

49.Haider A.W. Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death. / Haider A.W., Larson M.G., Benjamin E.J., Levy D. // J Am Coll Cardiol. – 1998. – Vol.32(5) – P.1454-1459

50.Rudominer R.L. Independent association of rheumatoid arthritis with increased left ventricular mass but not with reduced ejection fraction. / Rudominer R.L., Roman M.J., Devereux R.B., Paget S.A., Schwartz J.E., Lockshin M.D., Crow M.K., Sammaritano L., Levine D.M., Salmon J.E. // Arthritis Rheum. – 2009.

–Vol.60(1). – P.22-29.

51.Vizzardi E. Aortic stiffness and left ventricular hypertrophy in rheumatoid arthritis: comment on the article by Rudominer et al.. / Vizzardi E., Cavazzana I.,

96

Ceribelli A., Tincani A., Dei Cas L., Franceschini F. // Arthritis Rheum. – 2009.

–Vol. 60(9). – P.2852-2853.

52.Giles J.T. Left ventricular structure and function in patients with rheumatoid arthritis, as assessed by cardiac magnetic resonance imaging. / Giles J.T., Malayeri A.A., Fernandes V., Post W., Blumenthal R.S., Bluemke D., Vogel-Claussen J., Szklo M., Petri M., Gelber A.C., Brumback L., Lima J., Bathon J.M. // Arthritis Rheum – 2010. –Vol.62(4). – P.940-951.

53.Guilleminault C. Obstructive sleep apnea: electromyographic and fiberoptic studies / Guilleminault C., Hill M.W., Simmons F.B., Dement W.C.. // Exp Neurol.

–1978. –Vol.62(1). – P.48-67.

54.Phillips C.L. Hypertension and obstructive sleep apnea. / Phillips C.L., O'Driscoll D.M.// Nat Sci Sleep. – 2013. –Vol.5. – P. 43-52.

55.Gonçalves S.C. Obstructive sleep apnea and resistant hypertension: a casecontrol study. / Gonçalves S.C., Martinez D., Gus M., de Abreu-Silva E.O., Bertoluci C., Dutra I., Branchi T., Moreira L.B., Fuchs S.C., de Oliveira A.C., Fuchs F.D. // Chest. – 2007. – Vol.132(6). – P.1858-1862.

56.Schulz R. Andreas S., working group Kreislauf und Schlaf of the German Sleep Society (DGSM). Sleep apnoea in heart failure. / Schulz R., Blau A., Börgel J., Duchna H.W., Fietze I., Koper I., Prenzel R., Schädlich S., Schmitt J., Tasci S. // Eur Respir J. – 2007. – Vol.29(6). – P.1201-1205.

57.Durgan D.J. Cerebrovascular consequences of obstructive sleep apnea. /Durgan D.J., Bryan R.M.Jr.// J Am Heart Assoc. – 2012. – Aug 24.

58.Shimizu M. Obstructive sleep apnea in RA patients and effect of CPAP on RA activity. / Shimizu M., Tachibana N., Hagasaka Y., Goto M. // Arthritis Rheum.

–2003. – Vol.48. – P.114.

97

59. Holman A.J. Prevalence of obstructive sleep apnea (OSA) in men with inflammatory arthritis. / Holman A.J., De Paso W.J. // Arthritis Rheum – 2004.

–Vol.50. – P.385.

60.Franklin K.A. Sleep apnoea and nocturnal angina. / Franklin K.A., Nilsson J.B., Sahlin C., Näslund U. // Lancet. – 1995. – Vol.345(8957). – P.1085-1087.

61.Holman A.J. Considering cardiovascular mortality in patients with rheumatoid arthritis from different perspective:a role for autonomic dysregulation and

obstructive sleep apnea. / Holman A.J. // J Rheumatol. – 2007. – Vol.34(4).

–P. 671-673.

62.Sleep Apnea and Cardiovascular Disease EXPERT CONSENSUS DOCUMENT. // J Am Coll Cardiol. – 2008. – Vol.52. – P.686-717.

63.Ерошина В.А. Диагностика и лечение храпа и обструктивного апноэ сна/

Ерошина В.А., Бузунов Р.В. - М.: У-Фактория, 2003. — 48 с.

64.Caples S.M. Influence of cardiac function and failure on sleep-disordered breathing: evidence for a causative role / Caples S.M., Wolk R., Somers V.K. // J Appl Physiol. – 2005. – Vol.99(6). – P.2433-2439.

65.Gottlieb D.J. Prospective study of obstructive sleep apnea and incident coronary

heart disease and heart failure: the sleep heart health study. / Gottlieb D.J., Yenokyan G., Newman A.B., O'Connor G.T., Punjabi N.M., Quan S.F., Redline S., Resnick H.E., Tong E.K., Diener-West M., Shahar E. // Circulation. – 2010.

– Vol.122(4). – P. 352-360.

66.Gozal D. Cardiovascular morbidity in obstructive sleep apnea: oxidative stress, inflammation, and much more. / Gozal D., Kheirandish-Gozal L. // Am J Respir Crit Care Med. – 2008. – Vol.177(4). – P.369-375.

98

67. Chan K.H. Obstructive sleep aonea:novel trigger and potential therapeutic target for cardiac arrhythmias. / Chan K.H., Wilcox I. // Expert Rev Cardiovasc Ther. – 2010. – Vol.8(7). – P.981-994.

68.Shamsuzzaman A.S. Obstructive sleep apnea: implications for cardiac and vascular disease. / Shamsuzzaman A.S., Gersh B.J., Somers V.K. // JAMA. – 2003.

–Vol.290(14). – P.1906-1914.

69.Parish J.M. Obstructive sleep apnea and cardiovascular disease. / Parish J.M., Somers V.K. // Mayo Clin Proc. – 2004. – Vol.79. – P. 1036-1046.

70.Henskens L.H. Subjective sleep disturbance increases the nocturnal blood pressure level and attenuates the correlation with target-organ damage. / Henskens L.H., van Boxtel M.P., Kroon A.A., van Oostenbrugge R.J., Lodder J., de Leeuw P.W. // J Hypertens. – 2011. – Vol.29(2). – P.242-250.

71.Cutler M.J. Sleep apnea: from the nose to the heart. / Cutler M.J., Hamdan A.L., Hamdan M.H., Ramaswamy K., Smith M.L. // J Am Board Fam Pract. – 2002.

–Vol.15(2). – P.128-141.

72.Pelttari L.H Little effect of ordinary antihypertensive therapy on nocturnal high blood pressure in patients with sleep disordered breathing. / Pelttari L.H., Pelttari L.H., Hietanen E.K., Salo T.T., Kataja M.J., Kantola I.M. // Am J Hypertens.

–1998. – Vol.11. – P. 272-279.

73.Cuspidi C. Nocturnal nondipping and left ventricular hypertrophy in hypertension: an updated review. / Cuspidi C., Giudici V., Negri F., Sala C. // Expert Rev CardiovascTher. – 2010. – Vol.8(6). – P.781-792.

74.Lavie P. Sleep apnea syndrome: a possible contributing factor to resistant. / Lavie P., Hoffstein V. // Sleep. 2001. – Vol. 24(6) . – P.721-725.

99

75.Gami A.S. Day-night pattern of sudden death in obstructive sleep apnea. / Gami

A.S., Howard D.E., Olson E.J., Somers V.K.. // N Engl J Med. – 2005.

–Vol.352(12). – P.1206-1214.

76.Coumel P. Cardiac arrhythmias and the autonomic nervous system. / Coumel P. J // Cardiovasc Electrophysiol. – 1993. – Vol.4(3). – P.338-355.

77.Hanly P. ST-segment depression during sleep in obstructive sleep apnea. / Hanly P., Sasson Z., Zuberi N., Lunn K. // Am J Cardiol. – 1993. – Vol. 71(15).

–P.1341-1345.

78.Hirschfield G.M. C-reactive protein and cardiovascular disease: new insights

from an old molecule. / Hirschfield G.M., Pepys M.B. // QJM. – 2003.

– Vol.96(11). – P.793-807.

79.Biasucci L.M. Clinical use of C-reactive protein for the prognostic stratification of patients with ischemic heart disease. / Biasucci L.M., Liuzzo G., Colizzi C., Rizzello V. // Ital Heart J. – 2001. – Vol.2(3). – P.164-171.

80.Kasasbeh E. Inflammatory aspects of sleep apnea and their cardiovascular consequences./ Kasasbeh E., Chi D.S., Krishnaswamy G. // South Med J. – 2006.

–Vol.99(1). – P.58-67.

81.Minoguchi K. Increased carotid intima-media thickness and serum inflammatory markers in obstructive sleep apnea. / Minoguchi K., Yokoe T., Tazaki T., Minoguchi H., Tanaka A., Oda N., Okada S., Ohta S., Naito H., Adachi M. // Am J Respir Crit Care Med. – 2005. –Vol.172(5). – P.625-630.

82.Suzuki T. Obstructive sleep apnea and carotid-artery intima-media thickness. / Suzuki T., Nakano H., Maekawa J., Okamoto Y., Ohnishi Y., Yamauchi M., Kimura H. // Sleep. – 2004. – Vol.27(1). – P.129-133.

100

83.Drager L.F. Early signs of atherosclerosis in obstructive sleep apnea./ Drager L.F., Bortolotto L.A., Lorenzi M.C., Figueiredo A.C., Krieger E.M., Lorenzi-Filho G. // Am J Respir Crit Care Med. – 2005. – Vol.172(5). – P. 518-519.

84.Turmel J. Relationship between atherosclerosis and the sleep apnea syndrome:

An intravascular ultrasound study. / Turmel J., Sériès F., Boulet L.P., Poirier P.,

Tardif J.C., Rodés-Cabeau J., Larose E., Bertrand O.F. // Int J Cardiol. – 2009.

–Vol.132(2). – P. 203-209.

85.Marin J.M. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. / Marin J.M., Carrizo S.J., Vicente E., Agusti A.G. // Lancet. – 2005. – Vol.365(9464). –P.1046-1053.

86.Wang H. Influence of obstructive sleep apnea on mortality in patients with heart failure. / Wang H., Parker J.D., Newton G.E., Floras J.S., Mak S., Chiu K.L., Ruttanaumpawan P., Tomlinson G., Bradley T.D. // J Am Coll Cardiol. -2007.

–Vol.49(15). – P.1625-1631.

87.Young T. Epidemiology of obstructive sleep apnea: a population health perspective. / Young T., Peppard P.E., Gottlieb D.J. // Am J Respir Crit Care Med.

–2002. – Vol.165(9). – P.1217-1239.

88.Bounhoure J.P. Sleep apnea syndromes and cardiovascular disease. / Bounhoure

J.P., Galinier M., Didier A., Leophonte P. // Bull Acad Natl Med. – 2005.

– Vol.189(3). – P.445-459.

89.Kapur V.K. Sleep Heart Health Research Group.The relationship between chronically disrupted sleep and healthcare use. / Kapur V.K., Redline S., Nieto F.J.,

Young T.B., Newman A.B., Henderson J.A. // Sleep. – 2002. – Vol.25(3).

– P.289-296.